FDA Adverse Event Malfunction Summary report: N

ARCHITECT CA 19-9XR

MDR report key: 2924519 · Received January 22, 2013

Report

Report Number
1415939-2013-00019
Event Type
Malfunction
Date Received
January 22, 2013
Date of Event
January 14, 2013
Report Date
January 15, 2013
Manufacturer
ABBOTT LABORATORIES
Product Code
NIG
PMA / PMN Number
K052000
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ACCURACY OF THE REAGENT LOT 18070M500 WAS PERFORMED. FOUR LEVELS OF AN INTERNAL PANEL WERE TESTED ACROSS THREE ARCHITECT I SYSTEMS. EACH LEVEL CONTAINS A KNOWN CONCENTRATION OF THE CA 19-9 ANALYTE. THE RESULTS MET TESTING SPECIFICATIONS. A REVIEW OF COMPLAINT TRACKING AND TRENDING METRICS WAS PERFORMED AND IDENTIFIED NO ADVERSE TRENDS IN CONJUNCTION WITH THE COMPLAINT ISSUE CURRENTLY UNDER EVALUATION. THE ARCHITECT CA 19-9XR ASSAY PACKAGE INSERT CONTAINS INFORMATION TO ADDRESS THE CURRENT CUSTOMER ISSUE. THE CURRENT EVALUATION INDICATES THAT THE ARCHITECT CA 19-9XR REAGENT KIT IS PERFORMING AS INTENDED AND NO NEW ISSUES WERE FOUND. A PRODUCT MALFUNCTION WAS NOT IDENTIFIED.

Additional Manufacturer Narrative · 1

THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 02K91-35 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 02K91-27. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTS A FALSELY ELEVATED ARCHITECT CA 19-9XR ASSAY RESULT FOR ONE PATIENT. AN INITIAL RESULT OF 101.3 U/ML RETESTED AT 15.54 U/ML. NO SUSPECT RESULTS WERE REPORTED FROM THE LAB. THERE IS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
31394 ARCHITECT CA 19-9XR NIG ABBOTT LABORATORIES 18070M500

Patients

Seq Age Sex Outcome Treatment
1 56 YR ARCHITECT I2000SR LN:03M74-02 SN: (B)(4)| ARC I2000SR LN: 03M74-02 SN: (B)(4)